AGIO

AGIOS PHARMACEUTICALS INC

AGIO·00847X104·US·Common Stock·Healthcare - Biotechnology-13D/G

AGIO (AGIOS PHARMACEUTICALS INC) is held by 132 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($239.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($219.6M), STATE STREET CORP ($131.1M). Net institutional sentiment: Mixed. In Q2 2026, 2 members of Congress and 80 funds bought AGIO.

132
Holders
(10 Elite)
$1.9B
Total Value
61% (132)
Consensus
80 buying - 52 selling
13F: Insider & Congress: Updated regularly
AGIO

Smart Money Verdict

View all
Loading verdict
Held by 132 funds
10 elite

Who's Trading

Source dates: Price Oct 14, 2026 · Insiders Aug 6, 2026 · Activists Aug 3, 2026 · Congress Sep 10, 2026

CongressGilbert CisnerosGilbert CisnerosBuy $1,001 - $15,000Aug 20, 2026
InsiderGSGheuens SarahSell $914KAug 4, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
6.5M(+12.2%)$239.6M0.0%-5.44%
34
Increased
5.9M(+4.1%)$219.6M1.0%-0.11%
50
Increased
3.5M(+5.0%)$131.1M0.0%-4.89%
32
Increased
3.1M(+15.9%)$115.3M0.1%-0.63%
35
Increased
2.9M(+11.0%)$107.6M0.0%-9.33%
33
Increased
2.7M(+1.9%)$99.5M0.0%-8.62%
30
Decreased
2.2M(-20.3%)$82M0.6%-20.84%
0
Increased
2.1M(+41.2%)$78.3M0.1%+2.86%
47
Increased
1.6M(+7.3%)$58.4M0.0%-24.56%
32
Increased
1.4M(+2.3%)$51M0.0%+9.00%
30
Decreased
1.3M(-19.0%)$47.5M0.0%-11.43%
0
Increased
1.2M(+8.4%)$46.3M0.0%+2.47%
32
Increased
1.2M(+42.8%)$42.7M0.0%+1.10%
39
Increased
985,831(+643.8%)$36.6M0.0%-16.51%
47
Decreased
963,256(-0.4%)$35.7M0.0%-8.78%
0
Increased
873,560(+20.9%)$32.4M0.0%-4.98%
35
Increased
810,530(+223.6%)$30.1M0.0%-14.20%
46
Increased
732,687(+18.3%)$27.2M0.0%+1.57%
34
Increased
684,340(+1779.5%)$25.4M0.0%-16.31%
46
Unchanged
612,850$22.7M0.2%+5.33%
0

Showing 1-20 of 144

1 / 8
AGIOAGIOAGIOS PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used